Wallis and Futuna

Reimbursed Care Access

Wallis and Futuna are a French overseas collectivity where French national drug and medicines law largely applies; therefore established EU/France medical authorisations (e.g., esketamine/Spravato) are relevant and may be available under the same regulatory constraints as in metropolitan France, typically via hospital-based services and subject to French reimbursement/regulatory arrangements. Most classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) remain controlled as illicit/stupefiant substances in France and have no authorised medical use outside approved clinical research in the French system.